Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.570 -0.120 (-3.25%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,288,228
Open 3.660
Bid (Size) 3.570 (100)
Ask (Size) 3.600 (200)
Prev. Close 3.690
Today's Range 3.510 - 3.660
52wk Range 1.110 - 6.940
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire

Performance

YTD
+19.4%
+19.4%
1 Month
-5.8%
-5.8%
3 Month
-35.8%
-35.8%
6 Month
+47.5%
+47.5%
1 Year
+29.3%
+29.3%

More News

Read More
News headline image
Prime Medicine to Present at Jefferies Global Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
Via TokenRing AI
Topics Artificial Intelligence
News headline image
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗
Via Benzinga
News headline image
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗
Via Benzinga
News headline image
Prime Medicine to Participate in Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
PRME Revenue Misses by 73% ↗
Via The Motley Fool
News headline image
Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Align Technology Posts Downbeat Earnings, Joins Confluent,FormFactor And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Prime Medicine Announces Pricing of Public Offering
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Prime Medicine Announces Proposed Public Offering of Common Stock
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis
From Prime Medicine, Inc.
Via GlobeNewswire
News headline image
KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga

Frequently Asked Questions

Is Prime Medicine, Inc. - Common Stock publicly traded?
Yes, Prime Medicine, Inc. - Common Stock is publicly traded.
What exchange does Prime Medicine, Inc. - Common Stock trade on?
Prime Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prime Medicine, Inc. - Common Stock?
The ticker symbol for Prime Medicine, Inc. - Common Stock is PRME on the Nasdaq Stock Market
What is the current price of Prime Medicine, Inc. - Common Stock?
The current price of Prime Medicine, Inc. - Common Stock is 3.570
When was Prime Medicine, Inc. - Common Stock last traded?
The last trade of Prime Medicine, Inc. - Common Stock was at 12/24/25 01:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.